Symbols

GOCO

GoHealth·NASDAQ

--(--)

GOCO fundamentals

GOCO Q3 2025 Earnings

GoHealth (GOCO) released its earnings on Nov 13, 2025: revenue was 34.19M (YoY -71.10%), missed estimates; EPS was -11.8 (YoY -2665.22%), missed estimates.

Revenue / YoY

34.19M

-71.10%

EPS / YoY

-11.8

-2665.22%

Report date

Nov 13, 2025

GOCO Earnings Call Summary for Q3,2025

Strategic Pullback: Intentional 2025 MA volume reduction to preserve cash and focus on 95% retention vs. industry 85%.
SNP Leadership: 15% SNP market share; 70% 2026 SNP products non-commissionable to peers.
Growth Engine: GoHealth Protect up 40% YoY; $32M cash balance with no capital needs.
Consolidation Play: $1B+ M&A pipeline to acquire SNP-focused brokers at 5x EBITDA.

Earnings

EPS

Revenue

Revenue & Expenses

GOCO has released its 2025 Q3 earnings report, with revenue of 34.19M, reflecting a YoY change of -71.10%, and net profit of -313.92M, showing a YoY change of -2142.94%. The Sankey diagram below clearly presents GOCO's revenue sources and cost distribution.

Key Indicators

GoHealth (GOCO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

GoHealth (GOCO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

GoHealth (GOCO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

GoHealth (GOCO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown